GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Maccura Biotechnology Co Ltd (SZSE:300463) » Definitions » Pre-Tax Income

Maccura Biotechnology Co (SZSE:300463) Pre-Tax Income : ¥18 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Maccura Biotechnology Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Maccura Biotechnology Co's pretax income for the three months ended in Mar. 2025 was ¥29 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥18 Mil. Maccura Biotechnology Co's pretax margin was 5.77%.

During the past 13 years, Maccura Biotechnology Co's highest Pretax Margin was 29.82%. The lowest was 0.74%. And the median was 23.84%.


Maccura Biotechnology Co Pre-Tax Income Historical Data

The historical data trend for Maccura Biotechnology Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maccura Biotechnology Co Pre-Tax Income Chart

Maccura Biotechnology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 969.77 1,187.13 789.08 305.37 124.65

Maccura Biotechnology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 135.98 87.15 88.15 -186.63 29.44

Competitive Comparison of Maccura Biotechnology Co's Pre-Tax Income

For the Diagnostics & Research subindustry, Maccura Biotechnology Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maccura Biotechnology Co's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Maccura Biotechnology Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Maccura Biotechnology Co's Pre-Tax Income falls into.


;
;

Maccura Biotechnology Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Maccura Biotechnology Co's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=279.165+0+-22.12+6.447+-138.841
=125

Maccura Biotechnology Co's Pretax Income for the quarter that ended in Mar. 2025 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=52.461+0+-4.473+0.903+-19.451
=29

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Maccura Biotechnology Co  (SZSE:300463) Pre-Tax Income Explanation

Maccura Biotechnology Co's Pretax Margin for the quarter that ended in Mar. 2025 is calculated as

Pretax Margin=Pretax Income/Revenue
=29.44/510.258
=5.77%

During the past 13 years, Maccura Biotechnology Co's highest Pretax Margin was 29.82%. The lowest was 0.74%. And the median was 23.84%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Maccura Biotechnology Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Maccura Biotechnology Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Maccura Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
Number 8, 2nd Anhe Road, Hi-tech Zone, Chengdu, CHN, 611731
Maccura Biotechnology Co Ltd is a China-based in-vitro diagnostic (IVD) integration company engaged in the research and development, production and sales of IVD products. It is also engaged in the sales of foreign brands of in vitro diagnostic products as an agent. The company's developed product and technology development platforms cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.
Executives
Guo Lei Director
Wang Deng Ming Directors, executives
Wang Lin Supervisors
Wu Ming Jian Directors, executives
Shi Wei Directors, executives
Yang Hui Supervisors
Zhou Yue Guo Executives
Wang Zhen Executives
Yu Ping Executives
Zou Yuan Supervisors
Xu Sheng Guo Directors, executives
Liu Qi Lin Directors, executives
Chu Jian Jun Executives
Tang Yong Director
Xu Jin Song Executives

Maccura Biotechnology Co Headlines

No Headlines